清宣止咳颗粒联合西药治疗肺炎支原体肺炎的临床疗效及对患儿肺功能、免疫功能的影响  

Clinical Efficacy of Qingxuan Zhike Granules Combined with Western Medicine in the Treatment of Mycoplasma Pneumoniae Pneumonia and its Impact on Lung and Immune Function in Children

作　　者：秦俊峰 徐国超[1] 安云英 赵甜 QIN Junfeng;XU Guochao;AN Yunying(Xinxiang Central Hospital,Xinxiang Henan 453000)

机构地区：[1]新乡市中心医院,河南新乡453000

出　　处：《医学临床研究》2024年第2期269-272,共4页Journal of Clinical Research

摘　　要：【目的】探讨清宣止咳颗粒联合西药治疗肺炎支原体肺炎的临床疗效及对患儿肺功能、免疫功能的影响。【方法】选取2020年9月至2022年10月本院收治的112例肺炎支原体肺炎患儿,采用随机数字表法将其分为观察组和对照组,每组56例。对照组均予以常规西药治疗,观察组在对照组的基础上予以清宣止咳颗粒,两组均治疗2周。比较两组疗效、症状消失时间与治疗前后肺通气功能[第1秒用力呼气容积(FEV 1)、用力肺活量(FVC)、最大呼气流量(PEF)]、血清免疫球蛋白指标[免疫球蛋白M(IgM)、免疫球蛋白G(IgG)、免疫球蛋白A(IgA)]、Toll样受体4(TLR4)、髓样分化因子88(MyD88)、核转录因子-κB(NF-κB)水平,统计不良反应发生情况。【结果】观察组总有效率高于对照组,差异有统计学意义(P<0.05)。观察组退热时间、气促消失时间、咳嗽消失时间及肺部啰音消失时间短于对照组,差异有统计学意义(P<0.05)。治疗后,两组患者FEV 1、FVC、PEF均高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05);两组血清IgM、IgG、IgA水平高于治疗前,观察组高于对照组,差异有统计学意义(P<0.05);两组血清TLR4、MyD88、NF-κB表达水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。两组患儿不良反应发生率比较,差异无统计学意义(P>0.05)。【结论】清宣止咳颗粒联合西药治疗肺炎支原体肺炎的临床疗效较好,可有效改善患儿肺功能与免疫功能,抑制TLR4/MyD88表达,且安全性好。【Objective】To explore the clinical efficacy of Qingxuan Zhike Granules combined with Western medicine in the treatment of Mycoplasma pneumoniae pneumonia and its impact on lung function and immune function in children.【Methods】A total of 112 children with Mycoplasma pneumoniae pneumonia admitted to our hospital from September 2020 to October 2022 were selected and randomly divided into an observation group and a control group using a random number table method,with 56 cases in each group.The control group was treated with conventional western medicine,while the observation group was treated with Qingxuan Zhike Granules on the basis of the control group.Both groups were treated for 2 weeks.The two groups were compared in terms of efficacy,symptom disappearance time,and pulmonary ventilation function before and after treatment[forced expiratory volume at 1 second(FEV 1),forced vital capacity(FVC),maximum expiratory flow rate L(PEF)],serum immunoglobulin indicators[immunoglobulin M(IgM),immunoglobulin G(IgG),immunoglobulin A(IgA)],Toll like receptor 4(TLR4),myeloid differentiation factor 88(MyD88),and nuclear transcription factor-κB(NF-κB)levels.The occurrence of adverse reactions had been counted.【Results】The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).The observation group had shorter fever relief time,disappearance time of shortness of breath,disappearance time of cough,and disappearance time of lung rales compared to the control group,and the differences were statistically significant(P<0.05).After treatment,the FEV 1,FVC,and PEF of the two groups of patients were higher than before treatment,and the observation group was higher than the control group,with statistical significance(P<0.05);The serum levels of IgM,IgG,and IgA in the two groups were higher than before treatment,while the observation group was higher than the control group,with statistical significance(P<0.05);The expression levels of T

关 键 词：肺炎 支原体/中西医结合疗法 呼吸功能试验 免疫学试验 

分 类 号：R725.631[医药卫生—儿科]